Specifica, a Q² Solutions company, conducts antibody discovery campaigns using its proprietary Generation 3 library platform. Our goal is to generate as many different target-specific antibodies as possible to each client’s specifications. Our Generation 3 platform addresses the 4 main challenges of antibody discovery: speed, affinity, developability, and diversity. More than 80% of antibodies from our Generation 3 platform have no measurable biophysical liabilities, equaling the best therapeutic antibodies.